CM
AGN

Castleark Management’s Allergan Inc AGN Stock Holding History

Castleark Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-441
Closed -$138K – 453
2015
Q4 		$138K Buy
+441
New +$138K ﹤0.01% 367
2015
Q3 		– Sell
-441
Closed -$134K – 435
2015
Q2 		$134K Buy
+441
New +$134K ﹤0.01% 359
2015
Q1 		– Sell
-1,200
Closed -$255K – 411
2014
Q4 		$255K Hold
1,200
– – 0.01% 311
2014
Q3 		$149K Hold
1,200
– – ﹤0.01% 300
2014
Q2 		$203K Hold
1,200
– – 0.01% 305
2014
Q1 		$149K Hold
1,200
– – ﹤0.01% 300
2013
Q4 		$133K Hold
1,200
– – ﹤0.01% 307
2013
Q3 		$214K Hold
1,200
– – 0.01% 324
2013
Q2 		$101K Buy
+1,200
New +$124K ﹤0.01% 298

Other funds holding AGN

SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
AWM
Altavista Wealth Management Asheville, North Carolina $496M AUM 20.88% 1-Year Est. Return
CK
Carnick & Kubik Colorado Springs, Colorado $334M AUM 1.52% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
ODCM
Old Dominion Capital Management Charlottesville, Virginia $467M AUM 25.94% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
HHAA
Henry H. Armstrong Associates Pittsburgh, Pennsylvania $1.03B AUM 4.23% 1-Year Est. Return
AGA
Accuvest Global Advisors Provo, Utah $107M AUM 6.41% 1-Year Est. Return
LCM
Liberty Capital Management Birmingham, Michigan $582M AUM

Castleark Management's AGN Position: Q1 2016 in Review

Castleark Management sold out of Allergan Inc (AGN) in Q1 2016, closing a stake of 441 shares — an estimated $138K sold.

Castleark Management first reported a position in AGN in Q2 2013 and held it in 9 quarters. The position peaked at $255K in Q4 2014. 23 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

  • Castleark Management reported no remaining Allergan Inc position as of Q1 2016 after selling out during the quarter.
  • Castleark Management sold 441 Allergan Inc shares in Q1 2016, an estimated $138K.
  • Castleark Management first reported a position in Allergan Inc in Q2 2013 and held it in 9 quarters.
  • Castleark Management's Allergan Inc position peaked at $255K in Q4 2014.
  • 23 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2016.

Based on Castleark Management's 13F filing for Q1 2016, filed 17 May 2016.